Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze MRM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MRM investment potential.

What is MRM stock price today?

Get real-time MRM stock price, historical data, and price charts on Financhill. Track MRM performance with our advanced analysis tools.

Is MRM a good investment?

Evaluate MRM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MRM stock?

To buy MRM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MRM?

View detailed market capitalization data and company valuation metrics for MRM on our comprehensive analysis page.

What is the P/E ratio of MRM?

Use our fundamental analysis tools to view MRM P/E ratio and compare valuation metrics with industry peers.

What are MRM earnings?

View MRM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

MEDIROM Healthcare Technologies, Inc. 10K Form

Buy

MRM
MEDIROM Healthcare Technologies, Inc.

Last Price:

$2.13

Seasonality Move:

-9.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRM News And Ratings

See the #1 stock for the next 7 days that we like better than MRM

MRM Financial Statistics

Sales & Book Value

Annual Sales:	$54.8M
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$-0.46
Price / Book:	2.91

Profitability

EPS (TTM):	-0.11670
Net Income (TTM):	$-550.7K
Gross Margin:	$14.8M
Return on Equity:	0%
Return on Assets:	-1.31%

MEDIROM Healthcare Technologies, Inc. Earnings Forecast

Key MEDIROM Healthcare Technologies, Inc. Financial Ratios

The Gross Profit Margin over the past 7 years for MRM is 27.07%.
The Selling, General & Administrative Expenses for MRM have been equal to 27.01% of Gross Profit Margin.
The Research & Development expenses have been 0.42% of Revenue.
The Interest Expense is 36.00% of Operating Income.
The Net Earning history of MRM is 1.67% of Total Revenues.
Per Share Earnings over the last 7 years have been positive in 2 years.

MEDIROM Healthcare Technologies, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Diversified Consumer Services
Sector:	Consumer Discretionary
Current Symbol:	MRM
Website:	medirom.co.jp

Debt

Debt-to-Equity Ratio:	-4.42
Current Ratio:	0.34
Quick Ratio:	0.23

Price-to-Earnings

Trailing P/E Ratio:	12.72
Forward P/E Ratio:	0

MRM Technical Analysis vs Fundamental Analysis

Buy

MEDIROM Healthcare Technologies, Inc. (MRM) is a Buy

Is MEDIROM Healthcare Technologies, Inc. a Buy or a Sell?

MEDIROM Healthcare Technologies, Inc. stock is rated a Buy

The current MEDIROM Healthcare Technologies, Inc. [MRM] share price is $2.14. The Score for MRM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.